Connable Office Inc. bought a new position in Cantel Medical Corp. (NYSE:CMD) during the second quarter, Holdings Channel reports. The institutional investor bought 3,282 shares of the company’s stock, valued at approximately $256,000.

Several other large investors have also recently bought and sold shares of the company. Integrated Investment Consultants LLC bought a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $161,000. LS Investment Advisors LLC acquired a new position in Cantel Medical Corp. during the second quarter worth about $172,000. First Quadrant L P CA acquired a new position in Cantel Medical Corp. during the second quarter worth about $233,000. Cue Financial Group Inc. acquired a new position in Cantel Medical Corp. during the second quarter worth about $234,000. Finally, Bank of Montreal Can acquired a new position in Cantel Medical Corp. during the second quarter worth about $248,000. 83.88% of the stock is owned by institutional investors.

Shares of Cantel Medical Corp. (NYSE:CMD) opened at 73.79 on Friday. The company’s 50-day moving average price is $75.90 and its 200 day moving average price is $76.88. The company has a market cap of $3.06 billion, a P/E ratio of 43.66 and a beta of 1.23. Cantel Medical Corp. has a one year low of $68.19 and a one year high of $88.81.

Cantel Medical Corp. (NYSE:CMD) last issued its quarterly earnings data on Thursday, June 8th. The company reported $0.51 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.51. Cantel Medical Corp. had a return on equity of 17.75% and a net margin of 9.50%. The company had revenue of $192.10 million during the quarter, compared to analyst estimates of $193.84 million. The business’s revenue was up 10.6% compared to the same quarter last year. On average, equities research analysts anticipate that Cantel Medical Corp. will post $2.06 earnings per share for the current year.

The business also recently declared a semiannual dividend, which was paid on Monday, July 31st. Shareholders of record on Monday, July 17th were issued a dividend of $0.07 per share. This represents a yield of 0.18%. The ex-dividend date was Thursday, July 13th. Cantel Medical Corp.’s dividend payout ratio is presently 8.28%.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/12/connable-office-inc-takes-position-in-cantel-medical-corp-cmd.html.

CMD has been the topic of a number of recent analyst reports. Zacks Investment Research cut Cantel Medical Corp. from a “hold” rating to a “sell” rating in a research report on Monday, June 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a research note on Thursday, June 8th. Benchmark Co. lowered Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research note on Friday, June 9th. Finally, Sidoti raised Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a research note on Wednesday, August 2nd. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $91.67.

In other news, Chairman Charles M. Diker sold 35,000 shares of the business’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total value of $2,643,200.00. Following the transaction, the chairman now directly owns 3,114,520 shares in the company, valued at $235,208,550.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Charles M. Diker sold 13,000 shares of the business’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $76.36, for a total value of $992,680.00. Following the completion of the transaction, the chairman now owns 3,124,222 shares in the company, valued at $238,565,591.92. The disclosure for this sale can be found here. Insiders own 14.90% of the company’s stock.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.